6Kallen B,Danielesson BR. Fetal safety of erythromycin. An update of Swedish data[ J]. European Journal of Clinical Pharmacology,2014, 70(3) :355-360.
7Paul L. R, Gareth J. Nausea and the quest for the perfect anti-emetic [ J]. European Journal of Pharmacology,2014, 722:105 - 121.
8Hincapie JP, Castrillon CA, Yepes FL, et al, Microbiological effects of periodontal therapy plus azithromycin in patients with diabetes: results from a randomized clinical trial [ J ]. Acta Odontol Latinoam, 2014,27( 2): 89-95.
9Zarogoulidis P, Papanas N, Kinumis I, et al. Macrolides : from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases[ J]. Eur J Clin Pharmacol,2012, 68 ( 5 ) :479-503.
10Toledo Junior A, Daher AB, Amaral TA, et al. Poor response to azithromycin in cutaneous leishmaniasis leading to a premature interruption of a multicentric phase l~ clinical trial in Brazil [ J ]. Rev Soc Bras Med Trop,2014,47 ( 6 ) :756-762.
